Bile acid malabsorption – A novel indication for PCSK9 inhibitor therapy: 3 cases from a lipid clinic

Autor: Kim, E.J., Wierzbicki, A., Crook, M., Williams, J., Mcmahon, Z., Esan, O.
Zdroj: In Atherosclerosis August 2022 355
Databáze: ScienceDirect